Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 6/20 | 0.67 |
| ▸ | RAB9A | P51151 | 6/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.67 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.67 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.67 |
| ▸ | MAPT | P10636 | 3/20 | 0.67 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.67 |
| ▸ | LMNA | P02545 | 2/20 | 0.67 |
| ▸ | ELANE | P08246 | 2/20 | 0.52 |
| ▸ | CASP3 | P42574 | 2/20 | 0.47 |
| ▸ | SENP8 | Q96LD8 | 2/20 | 0.47 |
| ▸ | SENP7 | Q9BQF6 | 2/20 | 0.47 |
| ▸ | SENP6 | Q9GZR1 | 2/20 | 0.47 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.47 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.47 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.47 |
| ▸ | RELA | Q04206 | 1/20 | 0.47 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28689696 | 0.98 | NPC1 (0.65) | NPC1RAB9AALDH1A1SMN1; SMN2MAPK1 | |
| SCHEMBL20888346 | 0.83 | LMNA (0.46) | NPC1RAB9AALDH1A1SMN1; SMN2MAPK1 | |
| SCHEMBL3420776 | 0.82 | NPC1 (0.59) | NPC1RAB9AALDH1A1SMN1; SMN2MAPK1 | |
| SCHEMBL9324750 | 0.81 | NPC1 (0.62) | NPC1RAB9AALDH1A1SMN1; SMN2MAPK1 | |
| SCHEMBL36840 | 0.80 | NPC1 (1.00) | NPC1RAB9AALDH1A1SMN1; SMN2MAPK1 | |
| Anthraquinone SCHEMBL6310187 | 0.80 | NPC1 (1.00) | NPC1RAB9AALDH1A1SMN1; SMN2MAPK1 | |
| SCHEMBL29352712 | 0.80 | NPC1 (1.00) | NPC1RAB9AALDH1A1SMN1; SMN2MAPK1 | |
| SCHEMBL6412527 | 0.79 | BCHE (0.42) | NPC1RAB9AALDH1A1SMN1; SMN2MAPK1 | |
| SCHEMBL183313 | 0.79 | NPC1 (0.59) | NPC1RAB9AALDH1A1SMN1; SMN2MAPK1 | |
| SCHEMBL29530942 | 0.79 | NPC1 (0.59) | NPC1RAB9AALDH1A1SMN1; SMN2MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113025202-B | Acrylic acid modified epoxidized organic silicon photocureable coating and preparation method thereof | 长沙市湘鼎涂料有限公司 | 2022-04-15 | — | — | CN | claimed |
| CN-113025202-A | Acrylic acid modified epoxidized organic silicon photocureable coating and preparation method thereof | 管善月 | 2021-06-25 | — | — | CN | claimed |
| EP-0158865-A2 | Pregeneration of tetrahydroanthraquinone in a make-up solution to be added to a hydrogen peroxide working solution | FMC Corporation (US) | 1985-10-23 | — | — | EP | claimed |
| EP-0158864-A2 | Process for hydrogenating an alkylated anthraquinone | FMC Corporation (US) | 1985-10-23 | — | — | EP | claimed |
| US-4539196-A | Process for hydrogenating an alkylated anthraquinone | FMC CORPORATION (US) | 1985-09-03 | — | — | US | claimed |
| US-4514376-A | CYCLICALLY REDUCING, OXIDIZING AND EXTRACTING A SOLUTION CONTAINING ALKYLATED ANTHROQUINONE | FMC CORPORATION (US) | 1985-04-30 | — | — | US | claimed |
| US-12018315-B2 | Peptide nucleic acid functionalized hydrogel microneedles for sampling and detection of interstitial fluid nucleic acids | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2024-06-25 | — | — | US | disclosed |
| US-20230242969-A1 | PEPTIDE NUCLEIC ACID FUNCTIONALIZED HYDROGEL MICRONEEDLES FOR SAMPLING AND DETECTION OF INTERSTITIAL FLUID NUCLEIC ACIDS | HOWARD HUGHES MEDICAL INSTITUTE | 2023-08-03 | — | — | US | disclosed |
| CN-113025202-B | Acrylic acid modified epoxidized organic silicon photocureable coating and preparation method thereof | 长沙市湘鼎涂料有限公司 | 2022-04-15 | — | — | CN | disclosed |
| CN-113025202-A | Acrylic acid modified epoxidized organic silicon photocureable coating and preparation method thereof | 管善月 | 2021-06-25 | — | — | CN | disclosed |
| US-20210032222-A1 | FIVE-MEMBERED RING-SUBSTITUTED PYRIDAZINOL COMPOUNDS AND DERIVATIVES, PREPARATION METHODS, HERBICIDAL COMPOSITIONS AND APPLICATIONS THEREOF | QINGDAO KINGAGROOT CHEMICAL COMPOUND CO., LTD. (CN) | 2021-02-04 | — | — | US | disclosed |
| US-20210032229-A1 | PYRIDINE RING-SUBSTITUTED PYRIDAZINOL COMPOUNDS AND DERIVATIVES, PREPARATION METHODS, HERBICIDAL COMPOSITIONS AND APPLICATIONS THEREOF | QINGDAO KINGAGROOT CHEMICAL COMPOUND CO., LTD. (CN) | 2021-02-04 | — | — | US | disclosed |
| US-20200377929-A1 | PEPTIDE NUCLEIC ACID FUNCTIONALIZED HYDROGEL MICRONEEDLES FOR SAMPLING AND DETECTION OF INTERSTITIAL FLUID NUCLEIC ACIDS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2020-12-03 | — | — | US | disclosed |
| EP-1245534-A2 | Hydrogenation of a working solution in a hydrogen peroxide production process | KEMIRA CHEMICALS OY (FI) | 2002-10-02 | — | — | EP | disclosed |
| WO-2001066461-A1 | REGENERATION OF A WORKING SOLUTION IN A HYDROGEN PEROXIDE PRODUCTION PROCESS | KEMIRA CHEMICALS OY (FI) | 2001-09-13 | — | — | WO | disclosed |
| EP-0025620-B1 | PROCESS FOR THE PREPARATION OF SUBSTITUTED ANTHRAQUINONES | INTEROX Société Anonyme (BE) | 1983-06-22 | — | — | EP | disclosed |
| US-4355012-A | Mixed anthraquinonedisulfonic acids | AMERICAN COLOR & CHEMICAL CORPORATION (US) | 1982-10-19 | — | — | US | disclosed |
| US-4315068-A | CONTAINING A COBALT-AMMINE COMPLEX AND A DIOXIME OR A BISIMIDAZOLIN-3-ONE CHELATING AGENT; STABILITY; COLOR DILMS | RICOH CO., LTD. (JP) | 1982-02-09 | — | — | US | disclosed |
| US-4312811-A | DEHYDROCHLORINATION OF ORTHO-BENZOYLBENZOIC ACID CHLORIDE | INTEROX (SOCIETE ANONYME) (BE) | 1982-01-26 | — | — | US | disclosed |
| EP-0025620-A1 | Process for the preparation of substituted anthraquinones | INTEROX Société Anonyme (BE) | 1981-03-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210032229-A1 | PYRIDINE RING-SUBSTITUTED PYRIDAZINOL COMPOUNDS AND DERIVATIVES, PREPARATION METHODS, HERBICIDAL COMPOSITIONS AND APPLICATIONS THEREOF | CBR3, CBR1, H1-0 | NPC1 4527/4885RAB9A 3172/4885ALDH1A1 1438/4885 |
| US-20210032222-A1 | FIVE-MEMBERED RING-SUBSTITUTED PYRIDAZINOL COMPOUNDS AND DERIVATIVES, PREPARATION METHODS, HERBICIDAL COMPOSITIONS AND APPLICATIONS THEREOF | CBR3, CBR1, CYP8B1 | NPC1 4435/4885RAB9A 1211/4885ALDH1A1 983/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.